Share Price and Basic Stock Data
Last Updated: February 13, 2026, 10:01 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bilcare Ltd operates in the packaging and containers industry, focusing on providing innovative solutions. As of the latest reporting period, the company’s share price stood at ₹66.8, with a market capitalization of ₹157 Cr. The company reported total sales of ₹982 Cr for the fiscal year ending March 2023, which marks a decline from ₹1,827 Cr in FY 2020, reflecting ongoing challenges in revenue generation. Quarterly sales for September 2023 were recorded at ₹190 Cr, showing a slight increase from ₹182 Cr in June 2023 but still lower than the ₹234 Cr recorded in March 2023. Over recent quarters, there has been a consistent fluctuation in sales, indicating market volatility and potential operational inefficiencies. The trailing twelve months (TTM) revenue was ₹757 Cr, suggesting persistent struggle to maintain robust sales figures compared to historical performance and raising concerns over growth sustainability.
Profitability and Efficiency Metrics
Bilcare’s profitability metrics highlight significant challenges, as evidenced by a net profit of ₹-44 Cr for the year ending March 2025, following a net profit of ₹50 Cr in March 2023. The operating profit margin (OPM) stood at a mere 2% for FY 2025, down from 6% in FY 2023, indicating a deteriorating ability to convert sales into profit. The interest coverage ratio (ICR) was reported at 0.76x, reflecting difficulty in meeting interest obligations, which can constrain future borrowing capacity. The company also reported a return on equity (ROE) of 5.58% and a return on capital employed (ROCE) of 1.10%, both lower than typical industry standards, suggesting inefficiencies in generating returns for shareholders. Moreover, the cash conversion cycle (CCC) of 78 days indicates challenges in managing working capital effectively, further complicating profitability issues.
Balance Sheet Strength and Financial Ratios
Bilcare’s balance sheet reflects a challenging financial position, with total borrowings of ₹672 Cr against reserves of ₹430 Cr. This results in a total debt-to-equity ratio of 1.43x, which is indicative of a highly leveraged position, suggesting that the company is relying heavily on debt to finance its operations. The current ratio stood at 1.01x, indicating a tight liquidity position, while the quick ratio of 0.66x suggests potential difficulties in meeting short-term obligations. The company’s book value per share was reported at ₹199.21, down from ₹274.44 in the previous year, indicating a decline in net asset value. Furthermore, the enterprise value (EV) of ₹991.34 Cr relative to net operating revenue shows a valuation that may not reflect strong operational performance, raising concerns about investor confidence.
Shareholding Pattern and Investor Confidence
Bilcare’s shareholding structure reveals a significant presence of public investors at 69.94%, while promoters hold a stable 30.01% stake. Notably, foreign institutional investors (FIIs) account for a mere 0.04%, which may indicate a lack of interest from international investors in the company’s current performance and outlook. The number of shareholders has decreased from 23,419 in December 2022 to 16,513 as of September 2025, reflecting a decline in investor confidence. This trend could be concerning, as a shrinking shareholder base may lead to reduced liquidity and greater volatility in the stock price. The consistent promoter holding could provide some stability; however, the lack of institutional interest may hinder future capital inflows necessary for growth and expansion.
Outlook, Risks, and Final Insight
Bilcare Ltd faces a myriad of risks that could impede its recovery, including high leverage, declining sales, and persistent operational inefficiencies. The company’s weak profitability metrics and high debt levels could limit strategic flexibility and growth opportunities. Conversely, potential strengths include a loyal customer base and established market presence, which could be leveraged to improve operational performance. The stabilization of sales figures in recent quarters may indicate the possibility of a turnaround if effectively managed. In a positive scenario, Bilcare could enhance efficiency and profitability, attracting institutional investors and stabilizing its financial position. However, in a negative scenario, continued operational challenges could lead to further declines in profitability and investor confidence, necessitating urgent strategic interventions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 132 Cr. | 126 | 179/107 | 12.7 | 210 | 0.63 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 95.8 Cr. | 170 | 188/154 | 14.3 | 94.4 | 0.88 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 11.3 Cr. | 8.20 | 27.0/7.21 | 15.3 | 32.8 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 13.4 Cr. | 6.08 | 10.4/4.85 | 18.6 | 10.4 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 9,818 Cr. | 4,225 | 4,800/2,317 | 31.9 | 1,079 | 0.28 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 2,003.82 Cr | 326.66 | 40.76 | 189.00 | 0.33% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 254 | 246 | 234 | 182 | 190 | 175 | 200 | 194 | 202 | 198 | 194 | 186 | 178 |
| Expenses | 240 | 234 | 219 | 169 | 173 | 158 | 208 | 175 | 194 | 187 | 187 | 175 | 175 |
| Operating Profit | 14 | 12 | 14 | 13 | 17 | 17 | -8 | 19 | 8 | 11 | 7 | 11 | 3 |
| OPM % | 6% | 5% | 6% | 7% | 9% | 10% | -4% | 10% | 4% | 5% | 4% | 6% | 2% |
| Other Income | 10 | -6 | 231 | 3 | 1 | 4 | 9 | 4 | -6 | -6 | 21 | 6 | 4 |
| Interest | 16 | 16 | 11 | 19 | 20 | 21 | 23 | 21 | 24 | 19 | 18 | 19 | 19 |
| Depreciation | 9 | 10 | 9 | 10 | 10 | 11 | 13 | 12 | 11 | 12 | 12 | 12 | 12 |
| Profit before tax | -2 | -20 | 225 | -13 | -13 | -10 | -35 | -10 | -33 | -27 | -2 | -13 | -24 |
| Tax % | 60% | -6% | 65% | -1% | -5% | 34% | -44% | 55% | -10% | -40% | -432% | -25% | -1% |
| Net Profit | -3 | -19 | 78 | -13 | -12 | -14 | -20 | -15 | -30 | -16 | 5 | -10 | -23 |
| EPS in Rs | -2.42 | -7.98 | 19.63 | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.05 | 4.48 | -1.61 | -5.25 |
Last Updated: December 27, 2025, 7:05 pm
Below is a detailed analysis of the quarterly data for Bilcare Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 178.00 Cr.. The value appears to be declining and may need further review. It has decreased from 186.00 Cr. (Jun 2025) to 178.00 Cr., marking a decrease of 8.00 Cr..
- For Expenses, as of Sep 2025, the value is 175.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 175.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Jun 2025) to 3.00 Cr., marking a decrease of 8.00 Cr..
- For OPM %, as of Sep 2025, the value is 2.00%. The value appears to be declining and may need further review. It has decreased from 6.00% (Jun 2025) to 2.00%, marking a decrease of 4.00%.
- For Other Income, as of Sep 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Jun 2025) to 4.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 19.00 Cr..
- For Depreciation, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 12.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -24.00 Cr.. The value appears to be declining and may need further review. It has decreased from -13.00 Cr. (Jun 2025) to -24.00 Cr., marking a decrease of 11.00 Cr..
- For Tax %, as of Sep 2025, the value is -1.00%. The value appears to be increasing, which may not be favorable. It has increased from -25.00% (Jun 2025) to -1.00%, marking an increase of 24.00%.
- For Net Profit, as of Sep 2025, the value is -23.00 Cr.. The value appears to be declining and may need further review. It has decreased from -10.00 Cr. (Jun 2025) to -23.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -5.25. The value appears to be declining and may need further review. It has decreased from -1.61 (Jun 2025) to -5.25, marking a decrease of 3.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:03 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,062 | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 788 | 757 |
| Expenses | 2,819 | 2,506 | 2,396 | 2,443 | 2,617 | 2,827 | 1,782 | 572 | 784 | 925 | 708 | 743 | 724 |
| Operating Profit | 243 | 186 | 207 | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 45 | 33 |
| OPM % | 8% | 7% | 8% | 7% | 6% | 6% | 2% | 8% | 7% | 6% | 5% | 6% | 4% |
| Other Income | 24 | 9 | -87 | 107 | 297 | 59 | 254 | 45 | 44 | 237 | 16 | 12 | 25 |
| Interest | 217 | 236 | 151 | 176 | 249 | 283 | 174 | 76 | 69 | 60 | 82 | 82 | 76 |
| Depreciation | 141 | 191 | 164 | 177 | 416 | 378 | 239 | 46 | 39 | 38 | 45 | 46 | 47 |
| Profit before tax | -91 | -232 | -194 | -56 | -207 | -433 | -114 | -25 | -4 | 196 | -72 | -71 | -65 |
| Tax % | 25% | -7% | -58% | 42% | -4% | 5% | -13% | -55% | 3% | 74% | -18% | -21% | |
| Net Profit | -114 | -216 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -56 | -44 |
| EPS in Rs | -48.14 | -91.76 | -36.04 | -35.91 | -85.43 | -193.28 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -12.23 | -5.43 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -89.47% | 62.04% | 2.44% | -148.75% | -127.64% | 78.15% | 88.89% | 63.64% | 1350.00% | -218.00% | 5.08% |
| Change in YoY Net Profit Growth (%) | 0.00% | 151.51% | -59.60% | -151.19% | 21.11% | 205.78% | 10.74% | -25.25% | 1286.36% | -1568.00% | 223.08% |
Bilcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -12% |
| 5 Years: | -15% |
| 3 Years: | -2% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | -39% |
| 5 Years: | -10% |
| 3 Years: | -5% |
| Last Year: | -5% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 1,300 | 1,073 | 689 | 590 | 376 | -93 | 85 | 63 | 52 | 507 | 474 | 445 | 430 |
| Borrowings | 2,146 | 2,311 | 2,122 | 2,014 | 2,089 | 2,270 | 707 | 677 | 690 | 639 | 756 | 682 | 672 |
| Other Liabilities | 899 | 933 | 786 | 830 | 913 | 888 | 297 | 300 | 362 | 424 | 314 | 266 | 255 |
| Total Liabilities | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 1,380 |
| Fixed Assets | 2,126 | 1,926 | 2,432 | 2,403 | 2,180 | 2,005 | 534 | 494 | 465 | 1,045 | 1,038 | 949 | 930 |
| CWIP | 262 | 218 | 161 | 149 | 170 | 79 | 0 | 0 | 1 | 1 | 1 | 4 | 7 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 8 | 11 | 14 |
| Other Assets | 1,979 | 2,196 | 1,026 | 904 | 1,051 | 1,003 | 577 | 570 | 661 | 545 | 521 | 453 | 429 |
| Total Assets | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 1,380 |
Below is a detailed analysis of the balance sheet data for Bilcare Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 24.00 Cr..
- For Reserves, as of Sep 2025, the value is 430.00 Cr.. The value appears to be declining and may need further review. It has decreased from 445.00 Cr. (Mar 2025) to 430.00 Cr., marking a decrease of 15.00 Cr..
- For Borrowings, as of Sep 2025, the value is 672.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 682.00 Cr. (Mar 2025) to 672.00 Cr., marking a decrease of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 255.00 Cr.. The value appears to be improving (decreasing). It has decreased from 266.00 Cr. (Mar 2025) to 255.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,380.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,417.00 Cr. (Mar 2025) to 1,380.00 Cr., marking a decrease of 37.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 930.00 Cr.. The value appears to be declining and may need further review. It has decreased from 949.00 Cr. (Mar 2025) to 930.00 Cr., marking a decrease of 19.00 Cr..
- For CWIP, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 429.00 Cr.. The value appears to be declining and may need further review. It has decreased from 453.00 Cr. (Mar 2025) to 429.00 Cr., marking a decrease of 24.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,380.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,417.00 Cr. (Mar 2025) to 1,380.00 Cr., marking a decrease of 37.00 Cr..
However, the Borrowings (672.00 Cr.) are higher than the Reserves (430.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 241.00 | 184.00 | 205.00 | 188.00 | 159.00 | 168.00 | -662.00 | -626.00 | -630.00 | -582.00 | -717.00 | -637.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 125 | 35 | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 | 55 |
| Inventory Days | 103 | 105 | 108 | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 | 80 |
| Days Payable | 76 | 93 | 86 | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 | 57 |
| Cash Conversion Cycle | 132 | 137 | 57 | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 | 78 |
| Working Capital Days | 114 | 125 | 5 | -11 | -150 | -156 | -2 | -19 | -10 | -10 | 12 | -5 |
| ROCE % | 3% | 1% | 2% | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Diluted EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Cash EPS (Rs.) | -4.37 | -5.77 | 37.38 | 14.82 | 14.59 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 161.27 | 68.51 | 69.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 298.99 | 68.51 | 69.74 |
| Revenue From Operations / Share (Rs.) | 334.69 | 317.34 | 416.87 | 358.76 | 264.48 |
| PBDIT / Share (Rs.) | 26.79 | 26.19 | 28.45 | 31.86 | 29.45 |
| PBIT / Share (Rs.) | 7.30 | 7.10 | 12.39 | 15.18 | 10.12 |
| PBT / Share (Rs.) | -30.30 | -30.45 | 83.28 | -1.79 | -10.60 |
| Net Profit / Share (Rs.) | -23.86 | -24.86 | 21.32 | -1.85 | -4.74 |
| NP After MI And SOA / Share (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| PBDIT Margin (%) | 8.00 | 8.25 | 6.82 | 8.87 | 11.13 |
| PBIT Margin (%) | 2.18 | 2.23 | 2.97 | 4.23 | 3.82 |
| PBT Margin (%) | -9.05 | -9.59 | 19.97 | -0.50 | -4.00 |
| Net Profit Margin (%) | -7.12 | -7.83 | 5.11 | -0.51 | -1.79 |
| NP After MI And SOA Margin (%) | -3.65 | -4.44 | 1.53 | -1.49 | -3.38 |
| Return on Networth / Equity (%) | -6.14 | -6.67 | 7.29 | -16.75 | -24.42 |
| Return on Capital Employeed (%) | 1.59 | 1.37 | 2.32 | 4.93 | 3.17 |
| Return On Assets (%) | -2.03 | -2.12 | 0.94 | -1.11 | -1.98 |
| Long Term Debt / Equity (X) | 0.96 | 1.09 | 2.49 | 7.14 | 6.14 |
| Total Debt / Equity (X) | 1.43 | 1.52 | 3.09 | 9.18 | 7.85 |
| Asset Turnover Ratio (%) | 0.52 | 0.47 | 0.72 | 0.43 | 0.29 |
| Current Ratio (X) | 1.01 | 1.17 | 1.01 | 1.04 | 1.08 |
| Quick Ratio (X) | 0.66 | 0.87 | 0.76 | 0.70 | 0.75 |
| Inventory Turnover Ratio (X) | 7.06 | 5.47 | 6.44 | 3.73 | 3.31 |
| Interest Coverage Ratio (X) | 0.76 | 0.75 | 1.12 | 1.09 | 0.91 |
| Interest Coverage Ratio (Post Tax) (X) | 0.39 | 0.36 | -1.94 | 0.51 | 0.49 |
| Enterprise Value (Cr.) | 991.34 | 998.83 | 881.91 | 900.48 | 834.43 |
| EV / Net Operating Revenue (X) | 1.26 | 1.34 | 0.89 | 1.07 | 1.34 |
| EV / EBITDA (X) | 15.72 | 16.20 | 13.16 | 12.01 | 12.03 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| Price / BV (X) | 0.46 | 0.26 | 0.49 | 2.19 | 1.57 |
| Price / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| EarningsYield | -0.13 | -0.25 | 0.14 | -0.07 | -0.15 |
After reviewing the key financial ratios for Bilcare Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Diluted EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Cash EPS (Rs.), as of Mar 25, the value is -4.37. This value is below the healthy minimum of 3. It has increased from -5.77 (Mar 24) to -4.37, marking an increase of 1.40.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 334.69. It has increased from 317.34 (Mar 24) to 334.69, marking an increase of 17.35.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 26.79. This value is within the healthy range. It has increased from 26.19 (Mar 24) to 26.79, marking an increase of 0.60.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.10 (Mar 24) to 7.30, marking an increase of 0.20.
- For PBT / Share (Rs.), as of Mar 25, the value is -30.30. This value is below the healthy minimum of 0. It has increased from -30.45 (Mar 24) to -30.30, marking an increase of 0.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -23.86. This value is below the healthy minimum of 2. It has increased from -24.86 (Mar 24) to -23.86, marking an increase of 1.00.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 2. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For PBDIT Margin (%), as of Mar 25, the value is 8.00. This value is below the healthy minimum of 10. It has decreased from 8.25 (Mar 24) to 8.00, marking a decrease of 0.25.
- For PBIT Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 10. It has decreased from 2.23 (Mar 24) to 2.18, marking a decrease of 0.05.
- For PBT Margin (%), as of Mar 25, the value is -9.05. This value is below the healthy minimum of 10. It has increased from -9.59 (Mar 24) to -9.05, marking an increase of 0.54.
- For Net Profit Margin (%), as of Mar 25, the value is -7.12. This value is below the healthy minimum of 5. It has increased from -7.83 (Mar 24) to -7.12, marking an increase of 0.71.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.65. This value is below the healthy minimum of 8. It has increased from -4.44 (Mar 24) to -3.65, marking an increase of 0.79.
- For Return on Networth / Equity (%), as of Mar 25, the value is -6.14. This value is below the healthy minimum of 15. It has increased from -6.67 (Mar 24) to -6.14, marking an increase of 0.53.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 10. It has increased from 1.37 (Mar 24) to 1.59, marking an increase of 0.22.
- For Return On Assets (%), as of Mar 25, the value is -2.03. This value is below the healthy minimum of 5. It has increased from -2.12 (Mar 24) to -2.03, marking an increase of 0.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.96. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 0.96, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.43. This value exceeds the healthy maximum of 1. It has decreased from 1.52 (Mar 24) to 1.43, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has increased from 0.47 (Mar 24) to 0.52, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.17 (Mar 24) to 1.01, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.66, marking a decrease of 0.21.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.06. This value is within the healthy range. It has increased from 5.47 (Mar 24) to 7.06, marking an increase of 1.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 0.76, marking an increase of 0.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 3. It has increased from 0.36 (Mar 24) to 0.39, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 991.34. It has decreased from 998.83 (Mar 24) to 991.34, marking a decrease of 7.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 15.72. This value exceeds the healthy maximum of 15. It has decreased from 16.20 (Mar 24) to 15.72, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For Price / BV (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.46, marking an increase of 0.20.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For EarningsYield, as of Mar 25, the value is -0.13. This value is below the healthy minimum of 5. It has increased from -0.25 (Mar 24) to -0.13, marking an increase of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bilcare Ltd:
- Net Profit Margin: -7.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.59% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -6.14% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 40.76)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 1028, Shiroli, Rajgurunagar, Pune Maharashtra 410505 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shreyans Bhandari | Chairman & Managing Director |
| Ms. Kavita Bhansali | Executive Director |
| Mr. Rajesh Devene | Independent Director |
| Mrs. Madhuri Vaidya | Independent Director |
| Ms. Alka Sagar | Independent Director |
FAQ
What is the intrinsic value of Bilcare Ltd?
Bilcare Ltd's intrinsic value (as of 14 February 2026) is ₹129.81 which is 101.88% higher the current market price of ₹64.30, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹151 Cr. market cap, FY2025-2026 high/low of ₹116/52.4, reserves of ₹430 Cr, and liabilities of ₹1,380 Cr.
What is the Market Cap of Bilcare Ltd?
The Market Cap of Bilcare Ltd is 151 Cr..
What is the current Stock Price of Bilcare Ltd as on 14 February 2026?
The current stock price of Bilcare Ltd as on 14 February 2026 is ₹64.3.
What is the High / Low of Bilcare Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bilcare Ltd stocks is ₹116/52.4.
What is the Stock P/E of Bilcare Ltd?
The Stock P/E of Bilcare Ltd is .
What is the Book Value of Bilcare Ltd?
The Book Value of Bilcare Ltd is 193.
What is the Dividend Yield of Bilcare Ltd?
The Dividend Yield of Bilcare Ltd is 0.00 %.
What is the ROCE of Bilcare Ltd?
The ROCE of Bilcare Ltd is 1.10 %.
What is the ROE of Bilcare Ltd?
The ROE of Bilcare Ltd is 5.58 %.
What is the Face Value of Bilcare Ltd?
The Face Value of Bilcare Ltd is 10.0.